Category:
Active Pharmaceutical Ingredients
Injectafer (ferric derisomaltose) is an intravenous iron replacement therapy used for iron deficiency anemia. CAS: 9007-72-1 refers to the polymer matrix, not the drug itself. The core process involves chelation of ferric ions with derisomaltose ligands to ensure stability and slow release.
Contraindicated in patients with hypersensitivity to ferric derisomaltose. Strict monitoring for infusion reactions and hypophosphatemia is required. Store at controlled room temperature, protected from light, and do not freeze.